marijuana stocks

Insys Therapeutics misses 2Q profit forecasts

Insys Therapeutics posts 2Q profit of $7.3 million, result misses forecasts

 CHANDLER, Ariz. (AP) _ Insys Therapeutics Inc. (INSY) on Thursday reported second-quarter net income of $7.3 million.

The Chandler, Arizona-based company said it had net income of 10 cents per share. Earnings, adjusted for stock option expense and pretax expenses, came to 21 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.

The specialty pharmaceutical company posted revenue of $77.6 million in the period.

Insys Therapeutics shares have more than doubled since the beginning of the year. The stock has more than tripled in the last 12 months.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CANN Form 10-Q

Form 10-Q for ADVANCED CANNABIS SOLUTIONS, INC. 15-May-2015 Quarterly Report MANAGEMENT’S DISCUSSION…

4Front Ventures Corp. (FFNTF) to Report Fourth Quarter and Full Year 2023 Financial Results on April 15, 2024

4Front Ventures to Report Fourth Quarter and Full Year 2023 Financial Results…

$CANN Form 8-K

Form 8-K for ADVANCED CANNABIS SOLUTIONS, INC. 24-Feb-2015 Financial Statements and Exhibits…

 Green Thumb Industries Inc.(GTBIF) Industries Responds to Baseless Allegations by Chicago Tribune

Green Thumb Industries Responds to Baseless Allegations by Chicago Tribune Green Thumb…